THE USE OF PERGOLIDE, A POTENT DOPAMINE AGONIST, IN PARKINSONS-DISEASE

被引：12

作者：

LIEBERMAN, AN ^{[1
]}

GOLDSTEIN, M ^{[1
]}

NEOPHYTIDES, A ^{[1
]}

LEIBOWITZ, M ^{[1
]}

GOPINATHAN, G ^{[1
]}

WALKER, R ^{[1
]}

PACT, V ^{[1
]}

机构：

[1] NYU, SCH MED, NEW YORK, NY 10003 USA

来源：

关键词：

D O I：

10.1038/clpt.1982.128

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：70 / 75

页数：6

共 25 条

[1] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[2] CALNE DB, 1978, LANCET, V1, P735
[3] L-DOPA TREATMENT IN PARKINSONS DISEASE - EFFECT ON DOPAMINE AND RELATED SUBSTANCES IN DISCRETE BRAIN REGIONS
DAVIDSON, L
LLOYD, K
DANKOVA, J
HORNYKIEWICZ, O
[J]. EXPERIENTIA, 1971, 27 (09): : 1048 - +
[4] ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE
FAHN, S
[J]. NEUROLOGY, 1974, 24 (05) : 431 - 441
[5] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS
GOLDSTEIN, M
LIEBERMAN, A
LEW, JY
ASANO, T
ROSENFELD, MR
MAKMAN, MH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06): : 3725 - 3728
[6] Goldstein M, 1980, Adv Biochem Psychopharmacol, V23, P75
[7] GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P253
[8] GOLDSTEIN M, 1976, ADV PARKINSONISM, P236
[9] PARKINSONISM - ONSET PROGRESSION AND MORTALITY
HOEHN, MM
YAHR, MD
[J]. NEUROLOGY, 1967, 17 (05) : 427 - &
[10] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE
HORNYKIEWICZ, O
[J]. LIFE SCIENCES, 1974, 15 (07) : 1249 - 1259